katy28 and others,When will this mob ever learn. Shareholders...

katy28 and others,

When will this mob ever learn. Shareholders have a tendency to read the first couple of paragraphs and form an opinion about what is contained in the report. Now CBIO repeat their past mistakes and make good news look like bad news.

The non-executive Board Chairman Jones has not learnt any lessons.

I am not a Rhodes scholar and need some of these reports to at least let us have the outcome in layman's terms.

My take of the report is that although outcome was not perfect, it did show an improvement in the health of those trialled and especially those whom received the higher dose. That there are other plusses for the use of the drug that could be ascertained with further trials. Am I right?

Commercialisation of the drug still looks very viable.

I just wish that the layout of the report had been improved to show the positives.

As an aside, did anyone notice the play on bringing down the shareprice today, albeit, on low volumes. I suspect someone was playing games and looking for a big sell off so that they can accumulate. All IMO of course.

Good luck to all long term holders.